Oxygen-enhanced MRI assessment of tumour hypoxia in head and neck cancer is feasible and well tolerated in the clinical setting

European Radiology Experimental

Table 2 Characteristics of the squamous cell carcinomas for the 15 patients with histologically confirmed tumours

Patient number	Sex	Age (years)	Smoking	Site	Stage (TNM8)	p16	HPV DNA	Primary size (mL)	Lymph node masses
Patient number	Sex	Age (years)	Smoking	Site	Stage (TNM8)	p16	HPV DNA	Primary size (mL)	Number	Size (mL) Median (range)
1	M	54	Never	Palatine tonsil	T4aN2b	-	N/A	31.15	2	1.90 (1.31–2.50)
3	M	45	Current	Pyriform fossa	T2N2b	N/A	N/A	4.35	2	7.04 (4.27–9.81)
4	M	69	Ex	Oropharynx	T0N2	+	+	-	1	10.71
5	M	66	Never	Pyriform fossa	T2N1	+	+	3.98	2	6.26 (1.64–10.88)
6	M	46	Current	Nasopharynx	T1N2	N/A	N/A	8.83	10	2.60 (1.01–20.56)
7	M	66	Ex	Base of tongue	T4aN2	+	N/A	33.70	4	1.83 (0.37–6.44)
9	M	62	Never	Base of tongue	T1N1	+	+	1.31	1	11.98
10	M	55	Current	Base of tongue	T3N1	+	+	5.04	2	2.90 (0.26–5.55)
10	M	55	Current	Palatine tonsil	T3N0	+	+	17.69	−	−
11	M	72	Ex	Pyriform fossa	T4aN1	N/A	N/A	33.11	1	0.46
13	F	59	Current	Vallecula	T1N2c	-	-	0.54	1	9.94
14	M	56	Current	Palatine tonsil	T4aN2b	+	-	21.60	3	1.10 (0.48–8.40)
15	M	38	Current	Palatine tonsil	T1N1	+	+	2.35	7	2.62 (0.54–7.19)
16	M	65	Never	Palatine tonsil	T2N1	+	N/A	3.75	2	6.00 (0.93–11.07)
19	F	76	Never	Palatine tonsil	T2N1	+	+	4.55	1	8.35
20	M	57	Current	Larynx	T3N2b	N/A	N/A	7.20	2	1.52 (1.17–1.87)
		Median (range)						5.04 (0.26–33.70)	2 (1–10)	2.62 (0.26–20.56)
		Total number of lesions						15	41	-

All histology and staging were discussed at the local head and neck cancer multidisciplinary team meeting
HPV DNA Human papillomavirus deoxyribonucleic acid, N/A Not assessed